Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

TAK-279 effectively reduces psoriasis symptoms and is safe.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Finasteride reduces some inflammation in BPH but not all.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

Bimekizumab effectively treats scalp cellulitis and improves quality of life.

IL-17 and IL-23 inhibitors may cause hair loss.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Periplaneta americana extract helps hair regrowth by reducing inflammation and improving skin bacteria balance.

Periplaneta americana extract helps hair regrowth in alopecia areata by reducing inflammation and balancing skin bacteria.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Higher IL-17A levels indicate more severe alopecia areata.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.